134 related articles for article (PubMed ID: 17327350)
1. Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema.
Simó R; Carrasco E; Fonollosa A; García-Arumí J; Casamitjana R; Hernández C
Diabetes Care; 2007 Mar; 30(3):725-7. PubMed ID: 17327350
[No Abstract] [Full Text] [Related]
2. Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.
Simó R; Lecube A; Sararols L; García-Arumí J; Segura RM; Casamitjana R; Hernández C
Diabetes Care; 2002 Dec; 25(12):2282-6. PubMed ID: 12453974
[TBL] [Abstract][Full Text] [Related]
3. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema.
Shimada H; Akaza E; Yuzawa M; Kawashima M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2953-5. PubMed ID: 19060271
[TBL] [Abstract][Full Text] [Related]
4. Pars plana vitrectomy with and without peeling of the inner limiting membrane (ILM) for diabetic macular edema.
Gandorfer A; Kampik A
Retina; 2008 Jan; 28(1):187-8; author reply 188-9. PubMed ID: 18185166
[No Abstract] [Full Text] [Related]
5. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
6. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Er H
Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
[No Abstract] [Full Text] [Related]
7. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
8. Diabetic macular edema.
Narula R; Agarwal M; Chaudhary SP; Shroff C
Ophthalmology; 2009 Sep; 116(9):1833-4; author reply 1834. PubMed ID: 19729104
[No Abstract] [Full Text] [Related]
9. Diabetic macular edema.
Jonas J; Rensch F
Ophthalmology; 2009 Mar; 116(3):594-5; author reply 596-7. PubMed ID: 19264219
[No Abstract] [Full Text] [Related]
10. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
Liinamaa MJ; Savolainen MJ
Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the clinical role of vitreous fluorophotometry.
McCullough PC; Koester CJ; Campbell CJ; Anderson EA
Trans Am Ophthalmol Soc; 1983; 81():130-48. PubMed ID: 6676966
[No Abstract] [Full Text] [Related]
12. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
13. Diabetic macular edema.
Kim SJ
Ophthalmology; 2009 Jun; 116(6):1228.e1; author reply 1228-9. PubMed ID: 19486803
[No Abstract] [Full Text] [Related]
14. Diabetic macular edema.
Gillies M
Ophthalmology; 2009 Mar; 116(3):595; author reply 596-7. PubMed ID: 19264220
[No Abstract] [Full Text] [Related]
15. Fibrovascular membrane removal using a high-performance 25-gauge vitreous cutter.
Kadonosono K; Yamakawa T; Uchio E; Watanabe Y; Yanagi Y; Tamaki Y; Araie M
Retina; 2008; 28(10):1533-5. PubMed ID: 18728616
[No Abstract] [Full Text] [Related]
16. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
[TBL] [Abstract][Full Text] [Related]
17. Observations on diabetic retinopathy and macular degeneration.
Rice TA; Patz A
Sight Sav Rev; 1978; 48(2):71-6. PubMed ID: 568824
[No Abstract] [Full Text] [Related]
18. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
[TBL] [Abstract][Full Text] [Related]
19. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy.
Yorston D; Wickham L; Benson S; Bunce C; Sheard R; Charteris D
Br J Ophthalmol; 2008 Mar; 92(3):365-8. PubMed ID: 18303158
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activity.
Simó R; Lecube A; García-Arumí J; Carrasco E; Hernández C
Diabetes Care; 2004 Jan; 27(1):287-8. PubMed ID: 14694016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
